49,015
edits
Line 416: | Line 416: | ||
===General=== | ===General=== | ||
*Requires extensive sampling - to avoid missing an adenocarcinoma. | *Requires extensive sampling - to avoid missing an adenocarcinoma. | ||
Note: | |||
*The WHO prefers ''borderline'' over ''low malignant potential'' as the descriptor for these tumours.<ref name=pmid16100867>{{Cite journal | last1 = Acs | first1 = G. | title = Serous and mucinous borderline (low malignant potential) tumors of the ovary. | journal = Am J Clin Pathol | volume = 123 Suppl | issue = | pages = S13-57 | month = Jun | year = 2005 | doi = | PMID = 16100867 }}</ref> | |||
====Classification==== | ====Classification==== | ||
Line 421: | Line 424: | ||
# Intestinal type mucinous borderline tumour of the ovary ~ 90% of cases. | # Intestinal type mucinous borderline tumour of the ovary ~ 90% of cases. | ||
# Endocervical type mucinous borderline tumour of the ovary ~ 10% of cases.<ref name=Ref_GP419>{{Ref GP|419}}</ref> | # Endocervical type mucinous borderline tumour of the ovary ~ 10% of cases.<ref name=Ref_GP419>{{Ref GP|419}}</ref> | ||
===Gross=== | ===Gross=== |
edits